The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Trial in progress: A randomized phase II study of pembrolizumab with or without defactinib, a focal adhesion kinase inhibitor, following chemotherapy as a neoadjuvant and adjuvant treatment for resectable pancreatic ductal adenocarcinoma (PDAC).
 
John Davelaar
No Relationships to Disclose
 
Zachariah Brown
No Relationships to Disclose
 
Sheila Linden
No Relationships to Disclose
 
Christina Rodriguez
No Relationships to Disclose
 
Omer Elmadbouh
No Relationships to Disclose
 
Jonathan A. Pachter
Employment - Verastem
Leadership - Verastem
Stock and Other Ownership Interests - Verastem
Patents, Royalties, Other Intellectual Property - Verastem
 
Jun Gong
Honoraria - Amgen; Astellas Pharma; AVEO; Basilea Pharmaceutical; Bayer; Clinical Congress Consultants; Elsevier; EMD Serono; Exelixis; HalioDx; Janssen Biotech; Natera; QED Therapeutics
Consulting or Advisory Role - Amgen; Astellas Pharma; Clinical Congress Consultants; Elsevier; Exelixis; QED Therapeutics
 
Andrew Eugene Hendifar
Consulting or Advisory Role - Abbvie; Celgene; Eisai; Ipsen; Novartis; Perthera; Valar Labs
Research Funding - Ipsen; NGM Biopharmaceuticals (Inst)
Travel, Accommodations, Expenses - Halozyme
Other Relationship - FibroGen
 
Simon Lo
No Relationships to Disclose
 
Srinivas Gaddam
No Relationships to Disclose
 
Nicholas Nissen
No Relationships to Disclose
 
Richard A. Burkhart
No Relationships to Disclose
 
Lei Zheng
Stock and Other Ownership Interests - Alphamab; Mingruizhiyao; Z and L International Medical
Consulting or Advisory Role - Alphamab; Ambrx; AstraZeneca; BioArdis; Biosynergies; Coherent; datarevive; Foundation Medicine; Johnson & Johnson/Janssen; Merck; Merrimack; Mingruizhiyao; NovaGenesis; novarock; Snow Lake Capital; Xilio Therapeutics
Research Funding - Amgen; AstraZeneca (Inst); AstraZeneca (Inst); Bristol-Myers Squibb; Gradalis; Halozyme; InxMed; ITeos Therapeutics; Merck; NovaRock
Patents, Royalties, Other Intellectual Property - GVAX, licensed to Aduro Biotech.
Other Relationship - QED Therapeutics
 
Arsen Osipov
No Relationships to Disclose